Wells Fargo’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$230K Sell
12,326
-3,053
-20% -$56.9K ﹤0.01% 4310
2025
Q1
$279K Buy
15,379
+1,561
+11% +$28.3K ﹤0.01% 4034
2024
Q4
$301K Sell
13,818
-8,271
-37% -$180K ﹤0.01% 4044
2024
Q3
$605K Buy
22,089
+11,770
+114% +$322K ﹤0.01% 3510
2024
Q2
$267K Buy
10,319
+10,095
+4,507% +$261K ﹤0.01% 3968
2024
Q1
$6.72K Buy
224
+150
+203% +$4.5K ﹤0.01% 5444
2023
Q4
$769 Buy
74
+24
+48% +$249 ﹤0.01% 5847
2023
Q3
$684 Buy
50
+1
+2% +$14 ﹤0.01% 5916
2023
Q2
$591 Buy
49
+1
+2% +$12 ﹤0.01% 6142
2023
Q1
$608 Hold
48
﹤0.01% 6183
2022
Q4
$300 Sell
48
-92
-66% -$575 ﹤0.01% 6181
2022
Q3
$3K Sell
140
-210
-60% -$4.5K ﹤0.01% 5709
2022
Q2
$7K Buy
350
+244
+230% +$4.88K ﹤0.01% 5583
2022
Q1
$5K Sell
106
-663
-86% -$31.3K ﹤0.01% 6112
2021
Q4
$54K Sell
769
-972
-56% -$68.3K ﹤0.01% 5484
2021
Q3
$203K Buy
1,741
+1,712
+5,903% +$200K ﹤0.01% 4802
2021
Q2
$4K Sell
29
-133
-82% -$18.3K ﹤0.01% 6052
2021
Q1
$30K Sell
162
-975
-86% -$181K ﹤0.01% 5675
2020
Q4
$143K Buy
1,137
+394
+53% +$49.6K ﹤0.01% 5068
2020
Q3
$81K Sell
743
-1
-0.1% -$109 ﹤0.01% 5131
2020
Q2
$89K Sell
744
-469
-39% -$56.1K ﹤0.01% 5057
2020
Q1
$122K Sell
1,213
-46
-4% -$4.63K ﹤0.01% 4774
2019
Q4
$306K Sell
1,259
-882
-41% -$214K ﹤0.01% 4586
2019
Q3
$352K Buy
2,141
+265
+14% +$43.6K ﹤0.01% 4471
2019
Q2
$443K Buy
1,876
+1,345
+253% +$318K ﹤0.01% 4337
2019
Q1
$140K Buy
531
+493
+1,297% +$130K ﹤0.01% 4919
2018
Q4
$3K Buy
38
+2
+6% +$158 ﹤0.01% 5698
2018
Q3
$7K Buy
+36
New +$7K ﹤0.01% 5651